ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• My Worst Nightmare In RSTM: Accidental Unblinding

  Learn how collaborative efforts from study managers, supply managers, biostatisticians, designers, and clinicians can better protect the blind in clinical trials and prevent accidental unblinding.

• Transportation Solutions For Cell And Gene Therapy Supply Chains

  Developing a strong supply chain for your cell and gene therapy can make your company a more attractive target for acquisition as well as a more competitive player in the commercial environment.

• The Tale Of Two Clinical Supply Chains: The Risks Of Fragmented Systems

  Here we examine two contrasting approaches to showcase how a centralized inventory management system is an effective tool for supporting a robust supply chain.

• Clinical Manufacturing: What It Is And How It Works

  Clinical manufacturing is a specialized form of pharmaceutical manufacturing focused on producing drugs for clinical research. How does it work and how is it different from commercial manufacturing?

• RTSM Manages Clinical IP Dispensation In Schizophrenia Study

  Challenged by the dispensation of an investigational product (IP) across diverse patient subgroups, see what solution this pharma was able to utilize to ensure optimal distribution and minimize wastage.

• Biosample Tracking: A Consenting Dilemma

  Biosample collection is an inevitable part of most clinical trials. Learn how sponsors should be tracking every sample back to the source so as to not violate compliance issues.

• The Critical Role Of Clinical Trial Packaging Services In Trial Success

  Compliant, accurate packaging protects product integrity, supports dosing consistency, and keeps studies running smoothly. Smart components and controlled processes lower risk across complex trials.

• Key Considerations For Emerging Companies When Selecting Packaging Components

  Recognizing the importance of packaging development and prioritizing its role in drug development early on can help proactively identify potential delays and overcome risks.

• Breaking Down Early Small Molecule Development

  Adopt an integrated development strategy to streamline the path from early development to the clinic, ensuring timely clinical supply while reducing delays, risk, and inefficiencies.

• How Regional Logistics Strategy Supports Clinical Success In Europe

  In an era where trial delays, customs bottlenecks, and fragmented regulations can derail even the most promising program, logistics has become a strategic asset.